Evidence map›Paper›PMID 42373502›Full record

SynthesisZhonghua shao shang yu chuang mian xiu fu za zhi2026

[Organoid-based strategies and challenges in tissue regeneration].

G C Wang, J C Su

Abstract readEnglish AbstractSystematic Review
In one paragraph

Synthesis in Zhonghua shao shang yu chuang mian xiu fu za zhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

G C WangDepartment of Orthopedics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
J C SuDepartment of Orthopedics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.

Funding

Key Program of National Natural Science Foundation of China 82230071, 82530072Shanghai Disruptive Technology Innovation Project 25DIPA00400Shanghai Municipal Demonstration Project for Innovative Medical Device Application 23SHS05700Shanghai Municipal Health Commission New Medical Technology Research and Translation Seed Program 2024ZZ1001
6 · The paper itself

Abstract

Tissue regenerative medicine aims to repair or replace tissue and organs that have lost function due to disease, trauma, or aging, and the emergence of organoid technology has provided a new avenue for this field. Organoids are self-organized structures formed under three-dimensional culture conditions. They can recapitulate the structure and function of native organs, demonstrating unique advantages in disease modeling, drug screening, personalized medicine, and regenerative application. This article systematically summarizes the core strategies of organoids in tissue regeneration, including

Indexed as

OrganoidsRegenerationRegenerative MedicineTissue EngineeringHumans

Identifiers

PMID42373502
PMCPMC13333268

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.